Concept Life Sciences Ltd-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013127)
◆英語タイトル:Concept Life Sciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013127
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:27
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Concept Life Sciences Ltd (Concept Life Sciences), formerly Peakdale Molecular Ltd, a subsidiary of Concept Life Sciences Holdings Ltd is a provider of integrated discovery and development solution. The company services include integrated drug discovery and development services and analytical services. its analytical services include life sciences, food and consumer services, industrial and environmental services, chemicals and online reporting. The company caters its services to pharmaceutical, biotechnology, petrochemical, agrochemical, chemical and consumer products industries. It has operations across the UK. Concept Life Sciences is headquartered in Manchester, the UK.

Concept Life Sciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Concept Life Sciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 11
Partnerships 12
Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 12
Metrion Biosciences Enters into Agreement with Concept Life Sciences 13
Acquisition 14
Concept Life Sciences Acquires Aquila BioMedical 14
Concept Life Sciences Acquires CXR Biosciences 15
Concept Life Sciences Acquires Peakdale Molecular 16
Concept Life Sciences Acquires Scientific Analysis Laboratories 17
Concept Life Sciences Acquires Resource and Environmental Consultants 18
Concept Life Sciences Ltd – Key Competitors 19
Concept Life Sciences Ltd – Key Employees 20
Concept Life Sciences Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Sep 12, 2017: Concept Life Sciences expands into Alderley Park to support discovery services growth 22
Corporate Communications 23
Oct 24, 2017: Concept Life Sciences appoints Philip Payne as Chief Commercial Officer 23
Apr 03, 2017: Concept Life Sciences Further Strengthens Its Senior Team 24
Other Significant Developments 25
Mar 01, 2017: Concept Life Sciences Group Announces Multi-Million Pound Expansion Programme And Rebranding 25
Jun 14, 2016: Concept Life Sciences Groups Expands Its Services to the US 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Concept Life Sciences Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Concept Life Sciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 11
Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 12
Metrion Biosciences Enters into Agreement with Concept Life Sciences 13
Concept Life Sciences Acquires Aquila BioMedical 14
Concept Life Sciences Acquires CXR Biosciences 15
Concept Life Sciences Acquires Peakdale Molecular 16
Concept Life Sciences Acquires Scientific Analysis Laboratories 17
Concept Life Sciences Acquires Resource and Environmental Consultants 18
Concept Life Sciences Ltd, Key Competitors 19
Concept Life Sciences Ltd, Key Employees 20
Concept Life Sciences Ltd, Other Locations 21
Concept Life Sciences Ltd, Subsidiaries 21

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Concept Life Sciences Ltd-製薬・医療分野:企業M&A・提携分析(Concept Life Sciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆